Delayed occurrence of a severe cutaneous reaction in a multiple sclerosis patient taking interferon beta-1b

Allergy and Asthma Proceedings

Volumn 19, Issue 2, 1998, Pages 85-88

  Cohen, Bruce A ^a,b   Greenberger, Paul A ^a   Saini, Sunil ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Neurology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; INTERFERON BETA SERINE; INTERFERON BETA-1B; RECOMBINANT PROTEIN;

ADULT; ALLERGIC VASCULITIS; ARTICLE; CASE REPORT; DELAYED HYPERSENSITIVITY; DRUG ERUPTION; FEMALE; HUMAN; MULTIPLE SCLEROSIS; PATHOLOGY; SKIN;

ADULT; DRUG ERUPTIONS; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; INTERFERON-BETA; MULTIPLE SCLEROSIS; RECOMBINANT PROTEINS; SKIN; VASCULITIS, ALLERGIC CUTANEOUS;

EID: 0032009425     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/108854188778607200     Document Type: Article

References (2)

1. The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double blind placebo-controlled trial. Neurology 43:655-661, 1993.
2. The IFNB Multiple Sclerosis Study Group and the University British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology 45:1277-1285, 1995.